Sign in
Taking people in United StatesNo phase

CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry

Key facts

Who runs it
Universitätsklinikum Hamburg-Eppendorf
Where
Boston, Houston, Los Angeles, Minneapolis, Morristown, New York, Oklahoma City, Tampa, and Tucson, United StatesSee the 9 sitesAlso in 12 other countries, 34 sites
Trial code
Status
Recruiting
People taking part
1,000 people, planned
Started
1 Nov 2020
Expected to end
31 Dec 2030
Type of study
Observational, 4 groups
Record updated
7 May 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • clinically significant mitral insufficiency
  • patient underwent screening for TMVI
  • echocardiography data at baseline (and after TMVI, E2E and surgery)
  • follow-up of at least 30 days

Who cannot take part

  • age under 18 years

Where in United States

Also in 12 other countries, 34 sites

  • Brigham and Women's HospitalBoston, United StatesContact: Tsuyoshi Kaneko, MDTaking people
  • Houston Methodist HospitalHouston, United StatesContact: Michael Reardon, MDTaking people
  • Cedars-Sinai Medical Center_Los AngelesLos Angeles, United StatesContact: Raj Makkar, MDTaking people
  • Minneapolis Heart Institute at Abbott Northwestern HospitalMinneapolis, United StatesContact: Paul Sorajja, MDTaking people
  • Morristown Medical CenterMorristown, United StatesContact: Philippe Généreux, MDTaking people
  • Montefiore Medical CenterNew York, United StatesContact: Azeem Latib, MDTaking people
  • Oklahoma Heart HospitalOklahoma City, United StatesContact: Naeem Tahirkheli, MDTaking people
  • Tampa General HospitalTampa, United StatesContact: Hiram G. Bezerra, MDTaking people
  • Tucson Medical CenterTucson, United StatesContact: Thomas E. WaggonerTaking people

About the trial

What the trial wants to find out

This multinational, investigator-initiated registry aims to investigate clinical outcomes of patients undergoing transcatheter mitral valve replacement (TMVR). The registry primarily focuses on patients treated with TMVR in real-world clinical practice.

Read full original descriptionShow less

Patients evaluated for TMVR but not undergoing the procedure are no longer systematically included. Historical data may include such patients who subsequently underwent alternative treatments, including transcatheter edge-to-edge repair, mitral valve surgery, or medical/conservative therapy.

The 4 groups in the trial

  • Transcatheter Mitral Valve Replacement (TMVR)

    Patients with successful TMVR screening, who underwent Transcatheter Mitral Valve Replacement subsequently. All devices may be included.

  • Mitral transcatheter edge-to-edge repair (M-TEER)

    Patients with TMVR screening failure, who subsequently underwent interventional mitral valve edge-to-edge repair. Update: These patients are currently no longer systematically included.

  • Mitral valve surgery (Surgery)

    Patients with TMVR screening failure, who subsequently underwent mitral valve surgery (i.e., mitral valve repair or replacement). Update: These patients are currently no longer systematically included.

  • Medical/conservative therapy

    Patients with TMVR screening failure, who subsequently underwent conservative or optimal medical therapy. Update: These patients are currently no longer systematically included.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Choice of Optimal Transcatheter Treatment for Mitral Insufficiency Registry
Publications
Record updated
7 May 2026